Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By idatainsights
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Scynexis, Inc. - Product Pipeline Review – 2015 Now Available at iData Insights

% of readers think this story is Fact. Add your two cents.


Scynexis, Inc. – Product Pipeline Review – 2015 Summary Global Markets Direct s, Scynexis, Inc. – Product Pipeline Review – 2015, provides an overview of the Scynexis, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Scynexis, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope – The report provides brief overview of Scynexis, Inc. including business description, key information and facts, and its locations and subsidiaries – The report reviews current pipeline of Scynexis, Inc.s human therapeutic division and enlists all their major and minor projects – The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones – Special feature on out-licensed and partnered product portfolio – The report summarizes all the dormant and discontinued pipeline projects – Latest company statement – Latest news and deals relating to the Scynexis, Inc.s pipeline products Reasons to buy – Evaluate Scynexis, Inc.s strategic position with total access to detailed information on its product pipeline – Assess the growth potential of Scynexis, Inc. in its therapy areas of focus – Identify new drug targets and therapeutic classes in the Scynexis, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas – Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps – Develop strategic initiatives by understanding the focus areas of Scynexis, Inc. and exploit collaboration and partnership opportunities – Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage – Plan mergers and acquisitions effectively by identifying the most promising pipeline of Scynexis, Inc. – Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope – Explore the dormant and discontinued projects of Scynexis, Inc. and identify potential opportunities in those areas – Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landing-page.php?id=124198/scynexis-inc-product-pipeline-review-2015

To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landing-page.php?id=124198/scynexis-inc-product-pipeline-review-2015

Table of Contents

Table of Contents

2 List of Tables

4 List of Figures

4 Scynexis, Inc. Snapshot

5 Scynexis, Inc. Overview

5 Key Information

5 Key Facts

5 Scynexis, Inc.  Research and Development Overview

6 Key Therapeutic Areas

6 Scynexis, Inc. Pipeline Review

8 Pipeline Products by Stage of Development

8 Pipeline Products  Monotherapy

9 Pipeline Products PartneredProducts

10 Partnered Products/Combination Treatment Modalities

11 Pipeline Products  Out-Licensed Products

12 Out-Licensed Products/Combination Treatment Modalities

13 Scynexis, Inc.  Pipeline Products Glance

14 Scynexis, Inc.  Clinical Stage Pipeline Products

14 Phase II Products/Combination Treatment Modalities

14 Scynexis, Inc.  Early Stage Pipeline Products

15 Preclinical Products/Combination Treatment Modalities

15 Scynexis, Inc.  Drug Profiles

16 SCY-078

16 Product Description

16 Mechanism of Action

16 R&D Progress

16 Drugs for Fungal Infections

18 Product Description

18 Mechanism of Action

18 R&D Progress

18 ruclosporin

19 Product Description

19 Mechanism of Action

19 R&D Progress

19 Small Molecules to Inhibit Leucyl-tRNA Synthetase (LeuRS) for Human African Trypanosomiasis

20 Product Description

20 Mechanism of Action

20 R&D Progress

20 Scynexis, Inc.  Pipeline Analysis

21 Scynexis, Inc.  Pipeline Products by Target

21 Scynexis, Inc.  Pipeline Products by Route of Administration

22 Scynexis, Inc.  Pipeline Products by Molecule Type

23 Scynexis, Inc.  Pipeline Products by Mechanism of Action

24 Scynexis, Inc.  Recent Pipeline Updates

25 Scynexis, Inc.  Dormant Projects

26 Scynexis, Inc.  Locations And Subsidiaries

27 Head Office

 27 Other Locations & Subsidiaries

27 Appendix

28 Methodology

28 Coverage

28 Secondary Research

 28 Primary Research

28 Expert Panel Validation

28 Contact Us 28 Disclaimer 29

Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124197/laboratoires-pierre-fabre-sa-product-pipeline-review-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm.  We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

 

Contact Us: 
iData Insights

Tel: 1-866-237-2965

Web: http://www.idatainsights.com
Email: [email protected]

 

About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects. 

 



Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.